Mark Hermann, MD
Orthopaedic Surgery · Danville, VANPI 1740249416
Payments from drug & device makers
What this record shows
Arthrex accounts for 70.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $741 and has fallen 93.7% since, to $47 in 2024. That places this record below the midpoint for orthopaedic surgery clinicians in VA, where the typical reported total is $3,465.
Across 18 payments — averaging $57.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$724
- Amgen$67
- Avanos Medical$63
- Pacira Therapeutics, Inc.$60
- Johnson & Johnson$59
- Abbott$32
- plus $29 from 2 others
Across 71 payments — averaging $6206.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$190K
- Acadia Pharmaceuticals Inc$172K
- Anika Therapeutics, Inc.$68K
- Pfizer$11K
What the payments were for
- Travel & lodging$60058%
- Food & beverage$43442%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 3 | $724 |
| Amgen | 5 | $67 |
| Avanos Medical | 1 | $63 |
| Pacira Therapeutics, Inc. | 3 | $60 |
| Johnson & Johnson | 2 | $59 |
| Abbott | 2 | $32 |
| Bioventus LLC | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
How this compares
$1,034 in reported general payments places this provider in the 30th percentile of 473 orthopaedic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 150 | $5,653 |
| Meloxicam | 1,046 | $5,063 |
| Prednisone | 127 | $1,147 |
| Colchicine | 13 | $748 |
| Diclofenac Sodium | 39 | $737 |
| Ibuprofen | 35 | $444 |
| Baclofen | 32 | $197 |
| Tramadol Hcl | 14 | $56 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $20 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Danville
- Lawrence CohenDanville$468K
- Dale YoungNorth Chesterfield$10.9M
- James DowdVirginia Beach$6.1M
- Mark de BloisNorth Chesterfield$4M
- Cato LaurencinCharlottesville$3.5M
- Randall PeytonSterling$2.9M
- William MihalkoCharlottesville$2M
- David MillerNorth Chesterfield$1.7M
- Keith LawhornFairfax$1.6M
- Joseph GonduskyVirginia Beach$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.